6Vasey P. Survival and longer-term toxicity results of the SCOTROC study: docetaxel carboplatin (DC) vs. paclitaxd-carboplatin (PC) in epithelial ovarian cancer(E(X2)[J]. Proc Am Soc Clin Oncol, 2002,86 (1):19-25.
7Aravantinos G, Bafalonkos D,Fountzilas G, et al. Phase Ⅱ study of docetaxel-vinorelbine in platinum-resistant, paclitaxel-pretreated ovarian cancer[J]. Ann Oncol,2003,14(7) : 1094-1099.
8Veschraegen C F,Sittisomnong T, Kudelka A P, et al. Docetaxel for patients with paclitaxel-resistant mulovarian carcinomat[J]. J Clin Oncol,2000,18(14):2273-2739.